FDA Staff Reviewers Cast Doubt on Safety and Efficacy of Popular Peptides, Contrasting with Health Chief’s Advocacy
Washington D.C. – A significant divergence has emerged between the findings of U.S. Food and Drug Administration (FDA) staff reviewers and the public pronouncements of Health Secretary Robert F. Kennedy,…
Securities and Exchange Commission Closes Investigation into Faraday Future Despite Staff Recommendation for Enforcement Action
The U.S. Securities and Exchange Commission (SEC) has officially concluded its nearly four-year investigation into the electric vehicle (EV) startup Faraday Future Intelligent Electric Inc., a decision that comes despite…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple







